Advil Pm Tablet, Coated
NDC Package 67751-147-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Advil Pm (diphenhydramine citrate, ibuprofen) tablets is • do not take more than directed • adults and children 12 years and over: take 2 caplets at bedtime • do not take more than 2 caplets in 24 hours. This formulation utilizes a tablet, coated delivery system. Marketed by Navajo Manufacturing Company Inc., this product is identified by NDC 67751-147 and is authorized under FDA application NDA021394.

Identification & Billing

NDC Package Code
67751-147-01
Package Description
1 POUCH in 1 CARTON / 2 TABLET, COATED in 1 POUCH
Product Code
67751-147
11-Digit Billing Format
67751014701
RxNorm Crosswalk
  • RxCUI: 895664 - ibuprofen 200 MG / diphenhydrAMINE citrate 38 MG Oral Tablet
  • RxCUI: 895664 - diphenhydramine citrate 38 MG / ibuprofen 200 MG Oral Tablet

Clinical Specifications

Proprietary Name
Advil Pm
Non-Proprietary Name
Diphenhydramine Citrate, Ibuprofen
Substance Name
Diphenhydramine Citrate; Ibuprofen
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
• do not take more than directed • adults and children 12 years and over: take 2 caplets at bedtime • do not take more than 2 caplets in 24 hours

Regulatory & Marketing

Labeler Name
Navajo Manufacturing Company Inc.
Product Type
Human Otc Drug
FDA Application #
NDA021394
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
09-16-2016
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (67751-147). Click a package code to view its specific billing and regulatory data.

67751-147-02
2 POUCH in 1 CARTON / 4 TABLET, COATED in 1 POUCH
67751-147-06
3 POUCH in 1 CARTON / 2 TABLET, COATED in 1 POUCH

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67751-147-01 identifies a specific commercial package of 1 pouch in 1 carton / 2 tablet, coated in 1 pouch of Advil Pm, a human over the counter drug labeled by Navajo Manufacturing Company Inc.. This tablet, coated is formulated for oral use and contains diphenhydramine citrate; ibuprofen as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Navajo Manufacturing Company Inc. on September 16, 2016. The current certification is valid through December 31, 2027.

How is this Navajo Manufacturing Company Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67751014701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
67751-147-01
11-Digit CMS (5-4-2)
67751-0147-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.